Cost of Starting Colorectal Cancer Screening Programs: Results From Five Federally Funded Demonstration Programs
Authors:
- Florence K L TangkaFTFlorence K L Tangka
- Laura SeeffLSLaura Seeff
- Amy DeGroffADAmy DeGroff
- James GardnerJGJames Gardner
- A Blythe RyersonARA Blythe Ryerson
- Marion NadelMNMarion Nadel
- Janet RoyaltyJRJanet Royalty
- Sujha SubramanianSSSujha Subramanian
- Bela BapatBBBela Bapat
- 15 March 2008
- journal article
- Vol. 5 (2) , A47
Abstract
In 2005, the Centers for Disease Control and Prevention (CDC) started a 3-year colorectal cancer screening demonstration project and funded five programs to explore the feasibility of a colorectal cancer program for the underserved U.S. population. CDC is evaluating the five programs to estimate implementation cost, identify best practices, and determine the most cost-effective approach. The objectives are to calculate start-up costs and estimate funding requirements for widespread implementation of colorectal cancer screening programs. An instrument was developed to collect data on resource use and related costs. Costs were estimated for start-up activities, including program management, database development, creation of partnerships, public education and outreach, quality assurance and professional development, and patient support. Monetary value of in-kind contributions to start-up programs was also estimated. Start-up time ranged from 9 to 11 months for the five programs; costs ranged from $60,602 to $337,715. CDC funding and in-kind contributions were key resources for the program start-up activities. The budget category with the largest expenditure was labor, which on average accounted for 67% of start-up costs. The largest cost categories by activities were management (28%), database development (17%), administrative (17%), and quality assurance (12%). Other significant expenditures included public education and outreach (9%) and patient support (8%). To our knowledge, no previous reports detail the costs to begin a colorectal cancer screening program for the underserved population. Start-up costs were significant, an important consideration in planning and budgeting. In-kind contributions were also critical in overall program funding. Start-up costs varied by the infrastructure available and the unique design of programs. These findings can inform development of organized colorectal cancer programs.Keywords
This publication has 13 references indexed in Scilit:
- Start-Up of the Colorectal Cancer Screening Demonstration Program2008
- Development of a Federally Funded Demonstration Colorectal Cancer Screening Program2008
- Use of Colonoscopy for Colorectal Cancer Screening: Evidence from the 2000 National Health Interview SurveyCancer Epidemiology, Biomarkers & Prevention, 2005
- Cost estimation when time and resources are limited: The Brief DATCAPJournal of Substance Abuse Treatment, 2004
- Patterns and predictors of colorectal cancer test use in the adult U.S. populationCancer, 2004
- Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP)Drug and Alcohol Dependence, 2003
- Cost-Effectiveness Analyses of Colorectal Cancer ScreeningAnnals of Internal Medicine, 2002
- Which colon cancer screening test? A comparison of costs, effectiveness, and complianceThe American Journal of Medicine, 2001
- A structured instrument for estimating the economic cost of drug abuse treatmentJournal of Substance Abuse Treatment, 1997
- Training and employment programs in methadone treatment: Client needs and desiresJournal of Substance Abuse Treatment, 1992